STRS Ohio’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $201K | Sell |
1,167
-1
| -0.1% | -$185 | ﹤0.01% | 1493 |
|
|
2025
Q4 | $233K | Buy |
1,168
+2
| +0.2% | +$363 | ﹤0.01% | 1459 |
|
|
2025
Q3 | $182K | Hold |
1,166
| – | – | ﹤0.01% | 1583 |
|
|
2025
Q2 | $177K | Buy |
+1,166
| New | +$155K | ﹤0.01% | 1704 |
|
|
2025
Q1 | – | Sell |
-3,660
| Closed | -$676K | – | 1950 |
|
|
2024
Q4 | $676K | Sell |
3,660
-13,392
| -79% | -$2.58M | ﹤0.01% | 1006 |
|
|
2024
Q3 | $3.36M | Sell |
17,052
-23,504
| -58% | -$4.88M | 0.01% | 520 |
|
|
2024
Q2 | $8.38M | Sell |
40,556
-5,156
| -11% | -$1.17M | 0.03% | 397 |
|
|
2024
Q1 | $12.4M | Buy |
45,712
+10,752
| +31% | +$2.57M | 0.05% | 335 |
|
|
2023
Q4 | $8.26M | Buy |
34,960
+1,363
| +4% | +$268K | 0.03% | 386 |
|
|
2023
Q3 | $6.58M | Sell |
33,597
-89,586
| -73% | -$18.4M | 0.03% | 411 |
|
|
2023
Q2 | $25.9M | Sell |
123,183
-82,007
| -40% | -$16.3M | 0.11% | 215 |
|
|
2023
Q1 | $41.4M | Buy |
205,190
+6,190
| +3% | +$1.4M | 0.18% | 150 |
|
|
2022
Q4 | $43.4M | Buy |
199,000
+25,000
| +14% | +$5.46M | 0.2% | 140 |
|
|
2022
Q3 | $34.2M | Hold |
174,000
| – | – | 0.16% | 167 |
|
|
2022
Q2 | $37.2M | Buy |
174,000
+22,006
| +14% | +$5.38M | 0.17% | 155 |
|
|
2022
Q1 | $43.2M | Buy |
151,994
+15,702
| +12% | +$4.84M | 0.16% | 161 |
|
|
2021
Q4 | $51.4M | Buy |
136,292
+130,820
| +2,391% | +$50.8M | 0.18% | 136 |
|
|
2021
Q3 | $2.26M | Sell |
5,472
-365
| -6% | -$152K | 0.01% | 659 |
|
|
2021
Q2 | $2.16M | Sell |
5,837
-2,074
| -26% | -$693K | 0.01% | 731 |
|
|
2021
Q1 | $2.29M | Sell |
7,911
-33
| -0.4% | -$9.17K | 0.01% | 668 |
|
|
2020
Q4 | $1.98M | Buy |
7,944
+522
| +7% | +$124K | 0.01% | 703 |
|
|
2020
Q3 | $1.68M | Sell |
7,422
-1,093
| -13% | -$227K | 0.01% | 695 |
|
|
2020
Q2 | $1.48M | Buy |
8,515
+2,487
| +41% | +$397K | 0.01% | 721 |
|
|
2020
Q1 | $760K | Buy |
6,028
+840
| +16% | +$126K | ﹤0.01% | 846 |
|
|
2019
Q4 | $792K | Buy |
5,188
+2,511
| +94% | +$348K | ﹤0.01% | 1077 |
|
|
2019
Q3 | $354K | Sell |
2,677
-239
| -8% | -$32K | ﹤0.01% | 1463 |
|
|
2019
Q2 | $413K | Sell |
2,916
-426
| -13% | -$57.8K | ﹤0.01% | 1410 |
|
|
2019
Q1 | $485K | Sell |
3,342
-571
| -15% | -$75K | ﹤0.01% | 1300 |
|
|
2018
Q4 | $442K | Buy |
3,913
+951
| +32% | +$119K | ﹤0.01% | 1322 |
|
|
2018
Q3 | $398K | Sell |
2,962
-685
| -19% | -$84.5K | ﹤0.01% | 1486 |
|
|
2018
Q2 | $409K | Buy |
+3,647
| New | +$394K | ﹤0.01% | 1470 |
|
Other funds holding CRL
VCM
VPM
STRS Ohio's CRL Position: Q1 2026 in Review
STRS Ohio reduced its Charles River Laboratories (CRL) stake by 0.09% in Q1 2026, selling an estimated $185 and leaving 1,167 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.
STRS Ohio first reported a position in CRL in Q2 2018 and has held it in 31 quarters since. The position peaked at $51.4M in Q4 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- STRS Ohio held 1,167 shares of Charles River Laboratories worth $201K as of Q1 2026.
- STRS Ohio sold 1 Charles River Laboratories share in Q1 2026, an estimated $185.
- Charles River Laboratories made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1493 holding.
- STRS Ohio first reported a position in Charles River Laboratories in Q2 2018 and has held it in 31 quarters since.
- STRS Ohio's Charles River Laboratories position peaked at $51.4M in Q4 2021.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.